Rockville, MD, United States of America

Gil A Choi


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Gil A. Choi in Genetic Research**

Introduction

Gil A. Choi, based in Rockville, MD, is an inventor known for his significant contributions to genetic research and biotechnology. His work primarily focuses on the study of Staphylococcus aureus, a bacterium that poses considerable challenges in medical science. Through his innovative approach, he has contributed to understanding the genetic makeup of this organism, which can ultimately enhance therapeutic strategies.

Latest Patents

Choi holds one patent titled "Staphylococcus aureus polynucleotides and sequences." This patent details the polynucleotide sequences of the genome of Staphylococcus aureus, including the polypeptide sequences encoded by these polynucleotides. The patent also covers related vectors and hosts that comprise these polynucleotides, along with assays and various applications. Notably, this invention includes information that can be stored on computer-readable media, facilitating its use through computer-based systems and methods.

Career Highlights

Gil A. Choi is affiliated with Human Genome Sciences, Inc., where he collaborates on groundbreaking projects aimed at understanding human genetics and disease mechanisms. His role at this institution underscores his commitment to advancing the field of genomics and biotechnology.

Collaborations

Throughout his career, Choi has worked alongside notable colleagues such as Charles A. Kunsch and Steven C. Barash. These collaborations enhance the research output and foster innovative ideas within the realm of genetic studies.

Conclusion

Gil A. Choi exemplifies the innovative spirit that drives advancements in genetic research. His patent on Staphylococcus aureus polynucleotides represents a meaningful contribution to both science and potential applications in disease treatment. His ongoing work at Human Genome Sciences, Inc. continues to pave the way for future discoveries in the ever-evolving field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…